Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Canadian Headache Society Guideline: acute drug therapy for migraine headache.

Worthington I, Pringsheim T, Gawel MJ, Gladstone J, Cooper P, Dilli E, Aube M, Leroux E, Becker WJ; Canadian Headache Society Acute Migraine Treatment Guideline Development Group.

Can J Neurol Sci. 2013 Sep;40(5 Suppl 3):S1-S80. Review.

PMID:
23968886
2.

HIT-6 and MIDAS as measures of headache disability in a headache referral population.

Sauro KM, Rose MS, Becker WJ, Christie SN, Giammarco R, Mackie GF, Eloff AG, Gawel MJ.

Headache. 2010 Mar;50(3):383-95. doi: 10.1111/j.1526-4610.2009.01544.x. Epub 2009 Oct 8.

PMID:
19817883
3.

Demographics and clinical features of patients referred to headache specialists.

Jelinski SE, Becker WJ, Christie SN, Giammarco R, Mackie GF, Gawel MJ, Eloff AG, Magnusson JE.

Can J Neurol Sci. 2006 May;33(2):228-34.

PMID:
16736736
4.

Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada.

Jelinski SE, Becker WJ, Christie SN, Giammarco R, Mackie GF, Gawel MJ, Eloff AG, Magnusson JE.

Cephalalgia. 2006 May;26(5):578-88.

PMID:
16674767
5.

Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine.

Goldstein J, Gawel MJ, Winner P, Diamond S, Reich L, Davidson WJ, Sussman NM.

Headache. 1998 Jul-Aug;38(7):516-22.

PMID:
15613167
6.

Eletriptan.

Gawel MJ, Grujich NN.

Expert Opin Investig Drugs. 2001 Oct;10(10):1869-74. Review.

PMID:
11772292
7.

A systematic review of the use of triptans in acute migraine.

Gawel MJ, Worthington I, Maggisano A.

Can J Neurol Sci. 2001 Feb;28(1):30-41. Review.

PMID:
11252291
8.

Oral zolmitriptan is effective in the acute treatment of cluster headache.

Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ.

Neurology. 2000 May 9;54(9):1832-9.

PMID:
10802793
9.

The new triptans.

Gawel MJ.

Can J Clin Pharmacol. 1999 Autumn;6 Suppl A:20A-4A. Review.

PMID:
10494008
10.

Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies.

Damiano AM, Patrick DL, Guzman GI, Gawel MJ, Gelinas DF, Natter HM, Ingalls KK.

Med Care. 1999 Jan;37(1):15-26.

PMID:
10413388
11.

Guidelines for the nonpharmacologic management of migraine in clinical practice. Canadian Headache Society.

Pryse-Phillips WE, Dodick DW, Edmeads JG, Gawel MJ, Nelson RF, Purdy RA, Robinson G, Stirling D, Worthington I.

CMAJ. 1998 Jul 14;159(1):47-54.

12.

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group.

Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, Murphy MF, Natter HM, Norris FH, Rudnicki SA.

Neurology. 1997 Dec;49(6):1621-30.

PMID:
9409357
13.

Strategies for diagnosing and managing medication-induced headache.

Edmeads JG, Gawel MJ, Vickers J.

Can Fam Physician. 1997 Jul;43:1249-54. Review. Erratum in: Can Fam Physician 1997 Aug;43:1346.

14.

Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.

Pryse-Phillips WE, Dodick DW, Edmeads JG, Gawel MJ, Nelson RF, Purdy RA, Robinson G, Stirling D, Worthington I.

CMAJ. 1997 May 1;156(9):1273-87. Review. Erratum in: CMAJ 1997 Nov 15;157(10):1354.

15.

Recombinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study. North American ALS/IGF-I Study Group.

Lange DJ, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, Lai EC, Murphy MF, Natter HM, Norris FH, Rudnicki S.

Neurology. 1996 Oct;47(4 Suppl 2):S93-4; discussion S94-5. No abstract available.

PMID:
8858058
16.

Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings.

Cheung G, Gawel MJ, Cooper PW, Farb RI, Ang LC, Gawal MJ.

Radiology. 1995 Jan;194(1):263-70. Erratum in: Radiology 1995 Sep;196(3):800.

PMID:
7997565
17.

Subcutaneous sumatriptan in the treatment of acute episodes of posttraumatic headache.

Gawel MJ, Rothbart P, Jacobs H.

Headache. 1993 Feb;33(2):96-7.

PMID:
8384612
18.
19.
20.

Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.

Gawel MJ, Kreeft J, Nelson RF, Simard D, Arnott WS.

Can J Neurol Sci. 1992 Aug;19(3):340-5.

PMID:
1393843
21.

Central-nervous-system dysfunction after warm or hypothermic cardiopulmonary bypass.

Wong BI, McLean RF, Naylor CD, Snow WG, Harrington EM, Gawel MJ, Woods RB, Fremes SE.

Lancet. 1992 Jun 6;339(8806):1383-4.

PMID:
1350809
22.

Occipital nerve block in the management of headache and cervical pain.

Gawel MJ, Rothbart PJ.

Cephalalgia. 1992 Feb;12(1):9-13. Review.

PMID:
1559261
23.

The cluster diathesis.

Gawel MJ, Krajewski A, Luo YM, Ichise M.

Headache. 1990 Oct;30(10):652-5.

PMID:
2272816
24.

Evaluation of analgesic agents in recurring headache compared with other clinical pain models.

Gawel MJ, Szalai JF, Stiglick A, Aimola N, Weiner M.

Clin Pharmacol Ther. 1990 Apr;47(4):504-8.

PMID:
2328558
25.

Coping, social support, and depressive symptoms in Parkinson's disease.

Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ.

J Geriatr Psychiatry Neurol. 1990 Apr-Jun;3(2):85-90.

PMID:
2206263
26.

Diffuse Lewy body disease with dementia and oculomotor dysfunction.

Lewis AJ, Gawel MJ.

Mov Disord. 1990;5(2):143-7.

PMID:
2157979
27.

Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects.

Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ.

J Geriatr Psychiatry Neurol. 1990 Jan-Mar;3(1):3-9.

PMID:
2140682
28.

Reversal of cluster headache side following treatment of arteriovenous malformation.

Gawel MJ, Willinsky RA, Krajewski A.

Headache. 1989 Jul;29(7):453-4.

PMID:
2759853
29.

Intracranial haemodynamics in cluster headache.

Gawel MJ, Krajewski A.

Headache. 1988 Aug;28(7):484-7. No abstract available.

PMID:
3072317
30.

A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.

Riopelle RJ, Gawel MJ, Libman I, King DB, McLean DR, Paulseth R, Raphy B, Bouchard S.

Eur Neurol. 1988;28 Suppl 1:11-4.

PMID:
3288477
31.

A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.

Libman I, Gawel MJ, Riopelle RJ, Bouchard S.

Can J Neurol Sci. 1987 Nov;14(4):576-80.

PMID:
3319120
32.

The effects of exercise on platelet numbers and size.

Peatfield RC, Gawel MJ, Clifford-Rose F, Guthrie DL, Pearson TC.

Med Lab Sci. 1985 Jan;42(1):40-3. No abstract available.

PMID:
3982245
33.

A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial.

Gibberd FB, Park DM, Scott G, Gawel MJ, Fry DE, Page NG, Engler C, English JR, Rose FC.

J Neurol Neurosurg Psychiatry. 1982 Dec;45(12):1113-8.

34.

Platelet size: no correlation with migraine or monoamine oxidase activity.

Peatfield RC, Gawel MJ, Guthrie DL, Pearson TC, Glover V, Littlewood J, Sandler M, Rose FC.

J Neurol Neurosurg Psychiatry. 1982 Sep;45(9):826-9.

35.

Platelet function in migraineurs.

Gawel MJ, Rose FC.

Adv Neurol. 1982;33:237-42. Review. No abstract available.

PMID:
6459720
36.

Effect of levodopa on thyroid function and prolactin release. A study in patients with Parkinson's disease.

Lavin PJ, Gawel MJ, Das PK, Alaghband-Zadeh J, Rose FC.

Arch Neurol. 1981 Dec;38(12):759-60. No abstract available.

PMID:
6797388
37.

Asymmetry of the aura and pain in migraine.

Peatfield RC, Gawel MJ, Rose FC.

J Neurol Neurosurg Psychiatry. 1981 Sep;44(9):846-8.

38.

The effect of infused prostacyclin in migraine and cluster headache.

Peatfield RC, Gawel MJ, Rose FC.

Headache. 1981 Sep;21(5):190-5. No abstract available.

PMID:
7026501
39.

Reactive hyperaemia and migraine.

Peatfield RC, Gawel MJ, Rose FC.

Lancet. 1981 Aug 8;2(8241):305. No abstract available.

PMID:
6114344
40.

Pentoxifylline for prevention of transient ischaemic attacks.

Gawel MJ, Steiner TJ, Rose FC.

Lancet. 1981 Jun 6;1(8232):1266. No abstract available.

PMID:
6112592
41.

The effects of various drugs on speech.

Gawel MJ.

Br J Disord Commun. 1981 Apr;16(1):51-7. Review. No abstract available.

PMID:
6120001
42.

Visual and auditory evoked responses in patients with Parkinson's disease.

Gawel MJ, Das P, Vincent S, Rose FC.

J Neurol Neurosurg Psychiatry. 1981 Mar;44(3):227-32.

43.

The specific activity of platelet monoamine oxidase varies with platelet count during severe exercise and noradrenaline infusion.

Gawel MJ, Glover V, Burkitt M, Sandler M, Rose FC.

Psychopharmacology (Berl). 1981;72(3):275-7.

PMID:
6784146
44.

The influence of the infusion of noradrenaline on plasma cortisol levels in man.

Few JD, Gawel MJ, Imms FJ, Tiptaft EM.

J Physiol. 1980 Dec;309:375-89.

45.

Food allergy in migraine.

Merrett TG, Gawel MJ, Peatfield RC.

Lancet. 1980 Sep 6;2(8193):532. No abstract available.

PMID:
6105578
46.

Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan.

Baumgartner G, Gawel MJ, Kaeser HE, Pallis CA, Rose FC, Schaumburg HH, Thomas PK, Wadia NH.

J Neurol Neurosurg Psychiatry. 1979 Dec;42(12):1073-83.

47.

Exercise and hormonal secretion.

Gawel MJ, Park DM, Alaghband-Zadeh J, Rose FC.

Postgrad Med J. 1979 Jun;55(644):373-6.

48.

A delayed effect of noradrenaline infusion on plasma cortisol level in man [proceedings].

Few JD, Gawel MJ, Imms FJ, Tiptaft EM.

J Physiol. 1978 Sep;282:43P. No abstract available.

49.

Prolactin rise after a fall in blood-pressure.

Gawel MJ.

Lancet. 1977 Oct 15;2(8042):821. No abstract available.

PMID:
71628
50.

Mechanism for control of prolactin secretion.

Gawel MJ.

Lancet. 1977 May 14;1(8020):1059. No abstract available.

PMID:
67523

Supplemental Content

Loading ...
Support Center